UroGen Pharma (URGN) Financials: Revenue & Earnings

URGN price $33.74 -0.17 -0.50%

Ticker
URGN
Price
$33.74
Change
-0.17 -0.50%
Market cap ?
$1.65B
P/E ?
-17.75
Forward P/E ?
11.84
Dividend yield ?
0.00%
Beta ?
1.58
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
62
Value
53
Quality
33
Growth
99

Stocklytics score rationale: value 53, quality 33, growth 99.

Financials

2016201720182019202020212022202320242025
1753000081580001128000180001179900048042000643570008271300090398000109788000

UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization of solutions for urothelial and specialty cancers. It offers RTGel, a novel proprietary polymeric biocompatible, reverse thermal gelation hydrogel technology; Mitomycin a generic drug used off-label as an adjuvant chemotherapy for the treatment of low-grade NMIBC after trans-urethral resection of bladder tumor; Zusduri, a…

Fair value

URGN fair value $80.95. Price $33.74. Price is 58% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Compare URGN

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-05—0.10—90.58M
2026-08-05-0.28-0.2772.46M63.55M
2026-05-06-0.47-0.5650.96M44.83M
2026-03-02-0.54-0.5237.84M39.91M
2025-11-06-0.69-0.7227.48M40.13M
2025-08-07-1.05-0.8224.21M33.57M
2025-05-12-0.92-0.8320.25M23.26M
2025-03-10-0.80-0.6924.57M23.34M
2024-11-06-0.55-0.8425.20M26.13M
2024-08-13-0.91-0.8221.85M23.96M
2024-05-13-0.97-0.9318.78M21.38M
2024-03-14-0.72-0.6723.53M22.57M
2023-11-14-0.68-0.8920.85M22.57M
2023-08-10-1.03-1.1321.14M20.12M
2023-05-11-1.30-1.3917.19M17.18M
2023-03-16-1.22-1.1218.09M18.51M
2022-11-10-1.13-1.2216.10M20.15M
2022-08-11-1.18-1.3316.60M17.22M
2022-05-10-1.25-1.3613.56M15.17M
2022-03-21-1.27-1.1816.17M16.24M
2021-11-15-1.35-1.2611.35M15.42M
2021-08-04-1.17-1.1013.03M13.03M
2021-05-13-1.17-1.267.49M9.00M
2021-03-18-1.38-1.317.97M9.00M
2020-11-09-1.31-1.473.46M—
2020-08-10-1.44-1.55372.00K408.17K
2020-05-07-1.79-1.61—905
2020-03-02-1.86-1.69—16.45K
2019-11-12-1.06-1.26—21.91K
2019-08-09-1.08-1.2018.00K20.33K
2019-05-09-1.11-1.12—13.05M
2019-02-28-1.46-1.29——
2018-11-12-1.28-1.08283.00K221.01K
2018-08-14-1.14-0.91364.00K261.75K
2018-05-15-0.88-0.73481.00K374.11K
2018-03-15-0.74-0.65327.00K—
2017-11-14-0.020.087.81M11.25M
2017-08-14-0.70-0.57——
2017-05-061.12—17.53M—
2017-03-31-0.31—19.00K—

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-08Degnan ChrisBuy4.48K——
2026-10-08Degnan ChrisSell2.20K$36.6980.79K
2026-10-08Degnan ChrisSell4.48K——
2026-09-08Schoenberg MarkSell871$42.9237.38K
2026-09-08Smith Jason DrewSell1.52K$42.5464.62K
2026-09-07Schoenberg MarkBuy1.67K——
2026-09-07Schoenberg MarkSell1.67K——
2026-09-07Smith Jason DrewBuy3.33K——
2026-09-07Smith Jason DrewSell3.33K——
2026-08-26Robinson James A. Jr.Buy2.00K——
2026-08-26Robinson James A. Jr.Sell2.00K——
2026-08-20Schoenberg MarkSell60.68K$47.052.85M
2026-07-09Schoenberg MarkSell10.00K$40.00400.00K
2026-06-22Schoenberg MarkSell10.00K$35.01350.10K
2026-06-22Wildman Daniel GeorgeBuy10.00K$34.99349.90K
2026-06-22Wildman Daniel GeorgeBuy8.00K——
2026-06-22Robinson James A. Jr.Buy10.00K$34.99349.90K
2026-06-22Robinson James A. Jr.Buy8.00K——
2026-06-22Holden StuartBuy20.00K$34.99699.80K
2026-06-22BUTITTA CYNTHIA MBuy10.00K$34.99349.90K
2026-06-22BUTITTA CYNTHIA MBuy8.00K——
2026-06-22WEN LEANABuy10.00K$34.99349.90K
2026-06-22WEN LEANABuy8.00K——
2026-06-22Belldegrun ArieBuy20.00K$34.99699.80K
2026-06-08Schoenberg MarkBuy10.00K——
2026-06-08Schoenberg MarkSell5.22K$27.30142.56K
2026-06-08Schoenberg MarkSell10.00K——
2026-05-26Robinson James A. Jr.Buy2.00K——
2026-05-26Robinson James A. Jr.Sell2.00K——
2026-05-08Schoenberg MarkSell10.00K$30.00300.00K
2026-02-03Smith Jason DrewSell3.22K$19.6963.34K
2026-02-03Smith Jason DrewSell2.65K$19.6952.26K
2026-02-03Smith Jason DrewSell1.61K$19.6931.66K
2026-02-03Schoenberg MarkSell1.84K$19.6936.31K
2026-02-03Schoenberg MarkSell1.84K$19.6936.29K
2026-02-03Schoenberg MarkSell3.69K$19.6972.58K
2026-01-31Barrett Elizabeth A.Buy153.19K——
2026-01-31Smith Jason DrewBuy3.33K——
2026-01-31Smith Jason DrewBuy5.50K——
2026-01-31Smith Jason DrewBuy6.67K——
2026-01-31Smith Jason DrewBuy32.61K——
2026-01-31Smith Jason DrewSell3.33K——
2026-01-31Smith Jason DrewSell5.50K——
2026-01-31Smith Jason DrewSell6.67K——
2026-01-31Schoenberg MarkBuy6.67K——
2026-01-31Schoenberg MarkBuy3.33K——
2026-01-31Schoenberg MarkBuy3.33K——
2026-01-31Schoenberg MarkBuy20.00K——
2026-01-31Schoenberg MarkSell6.67K——
2026-01-31Schoenberg MarkSell3.33K——
2026-01-31Schoenberg MarkSell3.33K——
2026-01-31Degnan ChrisBuy32.61K——
2025-11-26Holden StuartSell2.00K——
2025-11-26Holden StuartBuy2.00K——
2025-11-26BUTITTA CYNTHIA MSell2.00K——
2025-11-26BUTITTA CYNTHIA MBuy2.00K——
2025-11-26Robinson James A. Jr.Sell2.00K——
2025-11-26Robinson James A. Jr.Buy2.00K——
2025-11-26WEN LEANASell2.00K——
2025-11-26WEN LEANABuy2.00K——
2025-11-26Wildman Daniel GeorgeSell2.00K——
2025-11-26Wildman Daniel GeorgeBuy2.00K——
2025-11-19Schoenberg MarkSell10.00K$25.00250.00K
2025-10-08Degnan ChrisSell4.48K——
2025-10-08Degnan ChrisBuy4.48K——
2025-10-08Degnan ChrisSell2.20K$16.8537.12K
2025-09-08Schoenberg MarkSell871$19.1116.64K
2025-09-08Smith Jason DrewSell1.52K$19.1129.05K
2025-09-07Schoenberg MarkBuy1.67K——
2025-09-07Schoenberg MarkSell1.67K——
2025-09-07Smith Jason DrewBuy3.33K——
2025-09-07Smith Jason DrewSell3.33K——
2025-08-26Wildman Daniel GeorgeBuy10.00K$19.50195.00K
2025-08-26Wildman Daniel GeorgeBuy8.00K——
2025-08-26Robinson James A. Jr.Buy10.00K$19.50195.00K
2025-08-26Robinson James A. Jr.Buy8.00K——
2025-08-26Holden StuartBuy10.00K$19.50195.00K
2025-08-26Holden StuartBuy8.00K——
2025-08-26BUTITTA CYNTHIA MBuy10.00K$19.50195.00K
2025-08-26BUTITTA CYNTHIA MBuy8.00K——
2025-08-26WEN LEANABuy10.00K$19.50195.00K
2025-08-26WEN LEANABuy8.00K——
2025-08-26Belldegrun ArieBuy20.00K$19.50390.00K
2025-08-11Schoenberg MarkSell10.00K$17.69176.90K
2025-07-28Barrett Elizabeth A.Buy87.61K——
2025-07-28Smith Jason DrewBuy16.50K——
2025-07-28Smith Jason DrewSell7.52K$19.14143.97K
2025-07-28Schoenberg MarkBuy10.00K——
2025-07-28Schoenberg MarkSell5.15K$19.1498.55K
2025-06-09Schoenberg MarkSell5.16K$7.3738.04K
2025-06-08Schoenberg MarkBuy10.00K——
2025-06-08Schoenberg MarkSell10.00K——
2025-02-26Robinson James A. Jr.Sell2.00K——
2025-02-26Robinson James A. Jr.Buy2.00K——
2025-01-31Schoenberg MarkBuy3.33K——
2025-01-31Schoenberg MarkBuy3.33K——
2025-01-31Schoenberg MarkSell1.90K$11.1421.12K
2025-01-31Schoenberg MarkSell1.90K$11.1421.12K
2025-01-31Schoenberg MarkBuy1.33K——
2025-01-31Schoenberg MarkSell759$11.148.46K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 199, holders +20 vs prior quarter. Ownership 84.47%.

HolderSharesChangeChange %Value
RTW INVESTMENTS, LP4.54M00.00%167.22M
BLACKROCK, INC.3.20M355.89K+12.51%117.81M
MORGAN STANLEY2.58M16.32K+0.64%94.81M
KYNAM CAPITAL MANAGEMENT, LP2.43M186.81K+8.31%89.58M
JEFFERIES FINANCIAL GROUP INC.2.20M00.00%80.95M
SG AMERICAS SECURITIES, LLC2.05M395.06K+23.83%75.55M
AMERICAN CENTURY COMPANIES INC1.69M48.15K+2.94%62.03M
ACORN CAPITAL ADVISORS, LLC1.67M00.00%61.58M
POINT72 ASSET MANAGEMENT, L.P.1.53M1.53MNew56.14M
FRONTIER CAPITAL MANAGEMENT CO LLC1.51M194.44K+14.80%55.51M
OPALEYE MANAGEMENT INC.1.44M10.00K+0.70%52.99M
SILVERARC CAPITAL MANAGEMENT, LLC1.30M-201.07K-13.38%47.91M
MENORA MIVTACHIM HOLDINGS LTD.1.15M00.00%42.41M
D. E. SHAW & CO., INC.1.15M122.66K+11.99%42.17M
STATE STREET CORP1.00M128.90K+14.74%36.91M
MPM BIOIMPACT LLC933.41K-10.39K-1.10%34.35M
SOLEUS CAPITAL MANAGEMENT, L.P.829.81K102.81K+14.14%30.54M
GOLDMAN SACHS GROUP INC819.83K221.31K+36.98%30.17M
MIGDAL INSURANCE & FINANCIAL HOLDINGS LTD.770.91K00.00%28.37M
ORBIMED ADVISORS LLC676.19K-199.30K-22.76%24.88M
GEODE CAPITAL MANAGEMENT, LLC610.36K86.53K+16.52%22.46M
WOODLINE PARTNERS LP500.73K00.00%18.43M
BOXER CAPITAL MANAGEMENT, LLC500.00K00.00%18.40M
BANK OF AMERICA CORP /DE/475.70K348.92K+275.21%17.51M
VANGUARD PORTFOLIO MANAGEMENT LLC456.56K47.00K+11.48%16.80M

Earnings and financials

UroGen Pharma Ltd. (URGN) trades at $33.74, with a market cap of $1.65B and a trailing P/E of -17.75. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
1753000081580001128000180001179900048042000643570008271300090398000109788000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

UroGen Pharma (URGN) Financials: Revenue & Earnings

URGN$33.74-0.17 -0.50%

$1.65B

Market Cap

-17.75

P/E

11.84

Forward P/E

62

Score

Price History